Dental CariesNCT02771522
Caries Lesion Activity in Orthodontic Patients - Calcivis System
A study testing Calcivis System in people with Dental Caries, run by Calcivis Ltd at 1 site in United Kingdom.
Trial summary
This is a prospective, single-centre clinical study to monitor caries lesion activity in orthodontic patients with the Calcivis System over a 12 week period. Dentists will identify patients who have had dental appliances in place for a minimum of 12 months and have visible white spot lesions on the anterior surfaces… Read more about this study
- Who is it for?
- Ages 12 to 100 years
- Conditions the study is for
- Dental Caries
- What is being tested?
- Calcivis System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 15 Feb 2017to 5 Jun 2018
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 100 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patient must be ≥ 12 years old
- Patient must have had orthodontic appliances placed on the upper incisors and / or canines for at least 12 months, and be ready for de-bond
- Patient must have at least one, active white spot lesion identified by the Calcivs System immediately post de-bond
- Patient and / or parent or guardian must be willing and able to give written informed consent
- Patient and / or parent or guardian must be willing and able to adhere to study schedule
Who cannot join
- Any Patient with recent tooth bleaching (within previous two weeks of imaging with the Calcivis System) or within the follow-up period
- Any patient currently taking part in a clinical research study, or who has taken part in a clinical research study in the previous three months
- Pregnant and / or nursing mothers
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Monitoring of Caries Lesion Activity in Orthodontic Patients With the Calcivis System
This is a prospective, single-centre clinical study to monitor caries lesion activity in orthodontic patients with the Calcivis System over a 12 week period. Dentists will identify patients who have had dental appliances in place for a minimum of 12 months and have visible white spot lesions on the anterior surfaces of incisors and / or canines at de-bond. Following de-bond, images of the tooth surface will be taken with the Calcivis System. Presence or absence of elevated luminescence on the images will indicate activity / inactivity. Only patients with at least one tooth identified as active with the Calcivis System will continue in the study and be followed up at 2, 4, 8 and 12 weeks de-bond. Images of the active teeth will be taken with the Calcivis System as before, at each follow-up visit.
The percentage of teeth showing luminescence using the Calcivis System will be calculated and summarised for all subjects for each post-baseline visit, and additionally by Investigator. This will then be summarised over all subjects for each post-baseline visit.
Read the detailed description
Dental caries (tooth decay) is a significant clinical and public health problem. The development of caries lesions involves a net mineral loss of dental tissue, which can lead to progressive loss of tooth structure and associated pain and disease. Detecting, assessing, diagnosis and treating such lesions are core activities in dentistry. Currently the main detection and diagnosis aids are visual inspection and the used of a probe, together with X-ray images. Determination of the activity status of a lesion (how likely it is to progress) is requires to assess treatment needs. Currently methods are problematic and involve the clinicians' subjective assessment and / or monitoring of lesions progression over a number of visits.
It is generally recognised and reported in the dental literature that patients undergoing orthodontic treatment with fixed appliances find it difficult to maintain meticulous oral hygiene and that, as a result, plaque accumulates adjacent to the orthodontic brackets (which are usually placed on the buccal, Free Smooth, surfaces of teeth, which are readily visible) holding the metal wires which are involved in moving the teeth - thus white spot lesions commonly develop at these sites of plaque stagnation. These lesions are, de facto, actively developing during orthodontic treatment, thus represent 'active lesions'. Once the wires and brackets are removed post-treatment, normal oral hygiene can be resumed, the plaque/biofilm over these lesions is readily removed and they become arrested, i.e. the demineralisation process ceases. Thus during a short period of time - a matter of weeks - there is usually a transition from active to inactive status for these 'orthodontically-induced' white spot lesions. By assessing and monitoring these lesions, using the Calcivis device, at relatively short intervals during this period of lesion status transition immediately post orthodontic treatment it would be possible to monitor the reduction in the demineralisation process as these lesions arrest.
A previous clinical study on the prototype of the Calcivis System has been conducted. The results concluded that the Calcivis System was safe for use and the level of agreement between elevated luminescence and areas of expected activity was above 70% and not due to chance (NCT02098304).
This prospective, single-centre clinical study has been designed to assess the use of the Calcivis System for monitoring the activity levels of post-orthodontic treatment white spot lesions over time. The Dentist will share the images with the patient
The device under evaluation comprises a hand-held customized intra-oral camera which takes both black \& white and luminescent images of a lesion on a tooth surface while simultaneously applying a photoprotein solution. The photo-protein detects free calcium ions on the tooth surface and produces a light signal if the caries lesion is active.
For the study, patients attending routine Orthodontic appointments to have their appliances checked, and who are identified by the Investigator as meeting the Inclusion and Exclusion criteria, and are ready for de-bond, will be approached to discuss their possible participation in the study.
Patients will be given a Patient Information Sheet to read and time to consider their participation in the study. If they are happy to participate they will asked to attend for five Study Visits - de-bond (baseline), 2, 4, 8 and 12 weeks. Written informed consent will be taken before any study procedures are conducted. As children under the age of 16 are included in this study, parent / guardian consent will be taken where appropriate.
At study Visit 1, demographics, relevant medications, oral hygiene and orthodontic history data will be collected.
The orthodontist will carry out an oral examination and the tooth / teeth identified as per inclusion / exclusion criteria, will be cleaned with prophy paste, rinsed with tap water and a 3-in-1 air / water spray before being air dried and staged as per ICDAS coding. Reference intra-oral photographs will be taken of each tooth. The free smooth tooth surfaces will again be air dried before taking the black \& white and luminescent images with the Calcivis System. After imaging is completed, patients rinse out with tap water. Adverse event will be collected throughout. The dentist will then share the images of the teeth with the patient. Post imaging questionnaires will be completed by each patient at the end of Study Visit 1 and user questionnaires completed by the dental team at the end of each Study Visit 1 day.
Only patients who have 'active' lesions on de-bond, as confirmed with the Calcivis System at the baseline visit, will be followed up in this study. If all lesions are assessed as 'inactive', the patient will be withdrawn from the study
Eligible patients will return for Study Visits at 2, 4, 8 and 12 weeks post-de-bond. At each of these visits, following a reference photograph of the teeth, each tooth which was "active" at Study Visit 1 will again be imaged with the Calcivis System as described above and the images shared with the patient. In addition, both Patient and User Questionnaires will be completed at the final Study Visit at 12 weeks.
- Conditions
- Dental Caries
- Being tested
- Calcivis System
- Keywords
- Caries, Acitivity, Demineralsiation
- Medical subject headings
- Dental Caries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Calcivis SystemDevice
Also called Calcivis Caries Activity Imaging System
Following de-bond, and identification of active post-orthodontic white spot lesions at baseline with the Calcivis System, each active tooth will be again be imaged at 2, 4, 8 and 12 weeks. Both black \& white and luminescent images images of the teeth are taken. The images of each tooth are overlaid and a resulting demineralization map of the tooth produced, indicating areas of elevated bioluminescence corresponding to free calcium ions on the surface of the tooth (active caries)
| Study group | Role | What they receive |
|---|---|---|
| Active post-othodontic lesions | Other | Imaging with the Calcivis System Receives: Device: Calcivis System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Presence or Absence of Elevated Luminescence
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time
Measured: 0, 2, 4, 8 and 12 weeks
Presence or Absence of Elevated Luminescence
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator
Measured: 0, 2, 4, 8 and 12 weeks post de-bond
Secondary outcomes (4)
Number of Non-patient Related Adverse Events With the Calcivis System
All adverse events and device deficiencies were collected throughout the study on Adverse Event Forms
Measured: 0 days, 2, 4, 8 and 12 weeks
Patient Experience
Completion of Patient Questionnaires after imaging with the Calcivis System
Measured: Baseline
Patient Experience
Completion of Patient Questionnaires after imaging with the Calcivis System at patient's final visit
Measured: Final Visit - either 8 or 12 weeks post debond
User Questionnaires
Completion of User Questionnaires after imaging with the Calcivis System
Measured: Baseline visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 May 2016 (estimated)
- Study start15 Feb 2017
- Primary completion5 Jun 2018
- Study completion5 Jun 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Dental CariesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Calcivis Ltd
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Medsource UK Ltd.
- Responsible party
- Sponsor
- Investigators
- Aman Ulhaq, BDS, MFDS, MSc, MOrtho, Study director, Edinburgh Dental InstitutieNiall McGuinness, FDS, MOrth, MSCD, DDS, PhD, Principal investigator, Edinburgh Dental InstituteEamon Howard-Bowles, BDS, MFDS, PG Cert, Principal investigator, Edinbuirgh Dental Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02771522
- Sponsor's protocol ID
- CAL-03-2015
- Status last verified
- Jun 2018
- First submitted
- 12 May 2016
- Last updated
- 28 Feb 2019
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Monitoring of Caries Lesion Activity in Orthodontic Patients With the Calcivis System
- ClinicalTrials.gov ID
- NCT02771522
- Acronym / sponsor ID
- CAL-03-2015
- Conditions
- Dental Caries
- Keywords
- Caries, Acitivity, Demineralsiation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Calcivis LtdIndustry (pharma, biotech, devices)
- Collaborators
- Medsource UK Ltd.
- Study start
- 15 Feb 2017 (actual)
- Primary completion
- 5 Jun 2018 (actual)
- Study completion
- 5 Jun 2018 (actual)
- First posted
- 13 May 2016 (estimated)
- Results
- Posted 28 Feb 2019
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a prospective, single-centre clinical study to monitor caries lesion activity in orthodontic patients with the Calcivis System over a 12 week period. Dentists will identify patients who have had dental appliances in place for a minimum of 12 months and have visible white spot lesions on the anterior surfaces of incisors and / or canines at de-bond. Following de-bond, images of the tooth surface will be taken with the Calcivis System. Presence or absence of elevated luminescence on the images will indicate activity / inactivity. Only patients with at least one tooth identified as active with the Calcivis System will continue in the study and be followed up at 2, 4, 8 and 12 weeks de-bond. Images of the active teeth will be taken with the Calcivis System as before, at each follow-up visit.
The percentage of teeth showing luminescence using the Calcivis System will be calculated and summarised for all subjects for each post-baseline visit, and additionally by Investigator. This will then be summarised over all subjects for each post-baseline visit.
Detailed description
Dental caries (tooth decay) is a significant clinical and public health problem. The development of caries lesions involves a net mineral loss of dental tissue, which can lead to progressive loss of tooth structure and associated pain and disease. Detecting, assessing, diagnosis and treating such lesions are core activities in dentistry. Currently the main detection and diagnosis aids are visual inspection and the used of a probe, together with X-ray images. Determination of the activity status of a lesion (how likely it is to progress) is requires to assess treatment needs. Currently methods are problematic and involve the clinicians' subjective assessment and / or monitoring of lesions progression over a number of visits.
It is generally recognised and reported in the dental literature that patients undergoing orthodontic treatment with fixed appliances find it difficult to maintain meticulous oral hygiene and that, as a result, plaque accumulates adjacent to the orthodontic brackets (which are usually placed on the buccal, Free Smooth, surfaces of teeth, which are readily visible) holding the metal wires which are involved in moving the teeth - thus white spot lesions commonly develop at these sites of plaque stagnation. These lesions are, de facto, actively developing during orthodontic treatment, thus represent 'active lesions'. Once the wires and brackets are removed post-treatment, normal oral hygiene can be resumed, the plaque/biofilm over these lesions is readily removed and they become arrested, i.e. the demineralisation process ceases. Thus during a short period of time - a matter of weeks - there is usually a transition from active to inactive status for these 'orthodontically-induced' white spot lesions. By assessing and monitoring these lesions, using the Calcivis device, at relatively short intervals during this period of lesion status transition immediately post orthodontic treatment it would be possible to monitor the reduction in the demineralisation process as these lesions arrest.
A previous clinical study on the prototype of the Calcivis System has been conducted. The results concluded that the Calcivis System was safe for use and the level of agreement between elevated luminescence and areas of expected activity was above 70% and not due to chance (NCT02098304).
This prospective, single-centre clinical study has been designed to assess the use of the Calcivis System for monitoring the activity levels of post-orthodontic treatment white spot lesions over time. The Dentist will share the images with the patient
The device under evaluation comprises a hand-held customized intra-oral camera which takes both black \& white and luminescent images of a lesion on a tooth surface while simultaneously applying a photoprotein solution. The photo-protein detects free calcium ions on the tooth surface and produces a light signal if the caries lesion is active.
For the study, patients attending routine Orthodontic appointments to have their appliances checked, and who are identified by the Investigator as meeting the Inclusion and Exclusion criteria, and are ready for de-bond, will be approached to discuss their possible participation in the study.
Patients will be given a Patient Information Sheet to read and time to consider their participation in the study. If they are happy to participate they will asked to attend for five Study Visits - de-bond (baseline), 2, 4, 8 and 12 weeks. Written informed consent will be taken before any study procedures are conducted. As children under the age of 16 are included in this study, parent / guardian consent will be taken where appropriate.
At study Visit 1, demographics, relevant medications, oral hygiene and orthodontic history data will be collected.
The orthodontist will carry out an oral examination and the tooth / teeth identified as per inclusion / exclusion criteria, will be cleaned with prophy paste, rinsed with tap water and a 3-in-1 air / water spray before being air dried and staged as per ICDAS coding. Reference intra-oral photographs will be taken of each tooth. The free smooth tooth surfaces will again be air dried before taking the black \& white and luminescent images with the Calcivis System. After imaging is completed, patients rinse out with tap water. Adverse event will be collected throughout. The dentist will then share the images of the teeth with the patient. Post imaging questionnaires will be completed by each patient at the end of Study Visit 1 and user questionnaires completed by the dental team at the end of each Study Visit 1 day.
Only patients who have 'active' lesions on de-bond, as confirmed with the Calcivis System at the baseline visit, will be followed up in this study. If all lesions are assessed as 'inactive', the patient will be withdrawn from the study
Eligible patients will return for Study Visits at 2, 4, 8 and 12 weeks post-de-bond. At each of these visits, following a reference photograph of the teeth, each tooth which was "active" at Study Visit 1 will again be imaged with the Calcivis System as described above and the images shared with the patient. In addition, both Patient and User Questionnaires will be completed at the final Study Visit at 12 weeks.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Active post-othodontic lesions | Other | Device: Calcivis SystemImaging with the Calcivis System |
Who may qualify
- Ages
- 12 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Patient must be ≥ 12 years old
- Patient must have had orthodontic appliances placed on the upper incisors and / or canines for at least 12 months, and be ready for de-bond
- Patient must have at least one, active white spot lesion identified by the Calcivs System immediately post de-bond
- Patient and / or parent or guardian must be willing and able to give written informed consent
- Patient and / or parent or guardian must be willing and able to adhere to study schedule
Key exclusion criteria (3 listed)
- Any Patient with recent tooth bleaching (within previous two weeks of imaging with the Calcivis System) or within the follow-up period
- Any patient currently taking part in a clinical research study, or who has taken part in a clinical research study in the previous three months
- Pregnant and / or nursing mothers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Calcivis SystemAlso: Calcivis Caries Activity Imaging SystemFollowing de-bond, and identification of active post-orthodontic white spot lesions at baseline with the Calcivis System, each active tooth will be again be imaged at 2, 4, 8 and 12 weeks. Both black \& white and luminescent images images of the teeth are taken. The images of each tooth are overlaid and a resulting demineralization map of the tooth produced, indicating areas of elevated bioluminescence corresponding to free calcium ions on the surface of the tooth (active caries) | Device | Active post-othodontic lesions |
Primary outcome
Presence or Absence of Elevated Luminescence
Time frame: 0, 2, 4, 8 and 12 weeks
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time
Presence or Absence of Elevated Luminescence
Time frame: 0, 2, 4, 8 and 12 weeks post de-bond
Percentage of active teeth showing luminescence (as measured by Calcivis System imaging) over time, per Investigator
4 secondary outcomes
Number of Non-patient Related Adverse Events With the Calcivis System
Time frame: 0 days, 2, 4, 8 and 12 weeks
Patient Experience
Time frame: Baseline
Patient Experience
Time frame: Final Visit - either 8 or 12 weeks post debond
User Questionnaires
Time frame: Baseline visit
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2019.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Dental Caries
Active, not recruiting
Clinical Evaluation of a New Dual-cure Universal Adhesive
Class I Dental Restorations, Class II Dental Restorations
Not yet recruiting
Safety of Intraosseous Anaesthesia in Children With Haemophilia
Haemophilia A, Haemophilia B
Not yet recruiting
Clinical and Radiographic Evaluation of Silver Diamine Fluoride Versus Light-Cured Silver Diamine Fluoride in Carious Primary Molars
Dental Caries
Not yet recruiting
Clinical Performance of CAD/CAM Hard Hybrid Ceramic Inlays Versus Resin Composite Inlays in Vital Molars With Extensive Occluso-Proximal Cavities
Dental Caries, Cavity, Dental
Not yet recruiting
Effect of Xylitol- Versus Erythritol-Sweetened Mints on Plaque ATP-Bioluminescence Readings
Dental Caries, Dental Plaque
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Aman Ulhaq, BDS, MFDS, MSc, MOrtho study director
Edinburgh Dental Institutie
Niall McGuinness, FDS, MOrth, MSCD, DDS, PhD principal investigator
Edinburgh Dental Institute
Eamon Howard-Bowles, BDS, MFDS, PG Cert principal investigator
Edinbuirgh Dental Institute
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Calcivis System in people with Dental Caries, run by Calcivis Ltd at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 28 Feb 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Presence or Absence of Elevated Luminescence (time frame: 0, 2, 4, 8 and 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2019.